These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 29944372)
1. Identification of Morpholino Thiophenes as Novel Mycobacterium tuberculosis Inhibitors, Targeting QcrB. Cleghorn LAT; Ray PC; Odingo J; Kumar A; Wescott H; Korkegian A; Masquelin T; Lopez Moure A; Wilson C; Davis S; Huggett M; Turner P; Smith A; Epemolu O; Zuccotto F; Riley J; Scullion P; Shishikura Y; Ferguson L; Rullas J; Guijarro L; Read KD; Green SR; Hipskind P; Parish T; Wyatt PG J Med Chem; 2018 Aug; 61(15):6592-6608. PubMed ID: 29944372 [TBL] [Abstract][Full Text] [Related]
2. Arylvinylpiperazine Amides, a New Class of Potent Inhibitors Targeting QcrB of Mycobacterium tuberculosis. Foo CS; Lupien A; Kienle M; Vocat A; Benjak A; Sommer R; Lamprecht DA; Steyn AJC; Pethe K; Piton J; Altmann KH; Cole ST mBio; 2018 Oct; 9(5):. PubMed ID: 30301850 [TBL] [Abstract][Full Text] [Related]
3. Pyrrolo[3,4-c]pyridine-1,3(2H)-diones: A Novel Antimycobacterial Class Targeting Mycobacterial Respiration. van der Westhuyzen R; Winks S; Wilson CR; Boyle GA; Gessner RK; Soares de Melo C; Taylor D; de Kock C; Njoroge M; Brunschwig C; Lawrence N; Rao SP; Sirgel F; van Helden P; Seldon R; Moosa A; Warner DF; Arista L; Manjunatha UH; Smith PW; Street LJ; Chibale K J Med Chem; 2015 Dec; 58(23):9371-81. PubMed ID: 26551248 [TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and evaluation of new 2-(quinoline-4-yloxy)acetamide-based antituberculosis agents. Borsoi AF; Paz JD; Abbadi BL; Macchi FS; Sperotto N; Pissinate K; Rambo RS; Ramos AS; Machado D; Viveiros M; Bizarro CV; Basso LA; Machado P Eur J Med Chem; 2020 Apr; 192():112179. PubMed ID: 32113048 [TBL] [Abstract][Full Text] [Related]
15. Intracellular and in vivo evaluation of imidazo[2,1-b]thiazole-5-carboxamide anti-tuberculosis compounds. Moraski GC; Deboosère N; Marshall KL; Weaver HA; Vandeputte A; Hastings C; Woolhiser L; Lenaerts AJ; Brodin P; Miller MJ PLoS One; 2020; 15(1):e0227224. PubMed ID: 31905374 [TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and anti-tubercular evaluation of new 2-acylated and 2-alkylated amino-5-(4-(benzyloxy)phenyl)thiophene-3-carboxylic acid derivatives. Part 1. Lu X; Wan B; Franzblau SG; You Q Eur J Med Chem; 2011 Sep; 46(9):3551-63. PubMed ID: 21641695 [TBL] [Abstract][Full Text] [Related]
18. Discovery of 5-methylpyrimidopyridone analogues as selective antimycobacterial agents. Wu Y; Cheung CY; Zhou Y; Wang Z; Tu Z; Cook GM; Lu X Bioorg Med Chem; 2021 Nov; 49():116426. PubMed ID: 34624820 [TBL] [Abstract][Full Text] [Related]
19. Identification of a small molecule with activity against drug-resistant and persistent tuberculosis. Wang F; Sambandan D; Halder R; Wang J; Batt SM; Weinrick B; Ahmad I; Yang P; Zhang Y; Kim J; Hassani M; Huszar S; Trefzer C; Ma Z; Kaneko T; Mdluli KE; Franzblau S; Chatterjee AK; Johnsson K; Mikusova K; Besra GS; Fütterer K; Robbins SH; Barnes SW; Walker JR; Jacobs WR; Schultz PG Proc Natl Acad Sci U S A; 2013 Jul; 110(27):E2510-7. PubMed ID: 23776209 [TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of moxifloxacin-acetyl-1,2,3-1H-triazole-methylene-isatin hybrids as potential anti-tubercular agents against both drug-susceptible and drug-resistant Mycobacterium tuberculosis strains. Gao F; Chen Z; Ma L; Fan Y; Chen L; Lu G Eur J Med Chem; 2019 Oct; 180():648-655. PubMed ID: 31352245 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]